<DOC>
	<DOCNO>NCT02029989</DOCNO>
	<brief_summary>The study 12-month , multi-centered , quasi-experimental design assess point-of-care ( POCT ) screening/monitoring subject antipsychotic agent metabolic syndrome . Subjects also randomize either Extended Treatment Group ( ETG ) define receive comprehensive medication management ( CMM ) pharmacist intervention Usual Treatment Group ( UTG ) receive CMM intervention . All subject recruit three community mental health clinic setting Minnesota .</brief_summary>
	<brief_title>Point-of-Care Testing ( POCT ) Detection Management Metabolic Syndrome Patients With Mental Illness</brief_title>
	<detailed_description>It well recognize patient antipsychotic agent mental illness continue affect severe health disparity due lack adequate metabolic monitoring.1-7 A major healthcare concern life-expectancy decrease ~25 year patient illnesses schizophrenia compare general population . Equally concern patient severe persistent mental illness ( SPMI ) continue inadequate integration care psychiatry medicine . Because difficulty get patient primary care hospital base laboratory , use capillary blood , point-of-care test ( POCT ) monitor glucose lipid addition vital sign anthropometric measurement community mental health center might prove beneficial . It highly likely advanced level screen mental health setting may lead identify new metabolic abnormality improve treatment careful monitoring previously diagnose metabolic syndrome , diabetes , and/or hypertension antipsychotic treat patient . It hypothesize metabolic abnormality identify ; provide pharmacist CMM consultative service would reduce medication relate problem improve medication adherence , coordination care psychiatry primary care , outcomes metabolic index .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>English speaking Age 1864 Competent understand make medical choice independently Currently previously see CMM pharmacist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Antipsychotics</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Obesity</keyword>
	<keyword>Medication Therapy Management</keyword>
	<keyword>MTM</keyword>
	<keyword>Pharmacist</keyword>
	<keyword>Comprehensive Medication Management</keyword>
	<keyword>CMM</keyword>
	<keyword>Health Disparity</keyword>
	<keyword>Monitoring</keyword>
	<keyword>Point Care Testing</keyword>
	<keyword>Chronic Persistent Mental Illness</keyword>
</DOC>